Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study).
Ulrich S., Speich R., Domenighetti G., Geiser T., Aubert J.D., Rochat T., Huber L., Treder U., Fischler M., 2007/10/20. Swiss medical weekly, 137 (41-42) pp. 573-580. Peer-reviewed.
ici le détail